awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38301000-1E4A5288-EA37-47D4-9825-10FDF0FA4026
Q38301000-1E4A5288-EA37-47D4-9825-10FDF0FA4026
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38301000-1E4A5288-EA37-47D4-9825-10FDF0FA4026
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.
P2860
Q38301000-1E4A5288-EA37-47D4-9825-10FDF0FA4026
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38301000-1E4A5288-EA37-47D4-9825-10FDF0FA4026
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e6edfbf012f0ad30895408cad0d0e6e868cc5eb2
P2860
Fucosylation of disaccharide precursors of sialyl LewisX inhibit selectin-mediated cell adhesion.